100%/100% at all stages for Ovarian cancer is excellent. The nearest competitions have no where near close to this result, and yet market caps are in the $1b US range.
The details of the size of the population who could benefit is eye opening. A survivor of breast cancer - knowing that the risk of relapse is very real, a blood test every 3-6 months to keep an eye on cancer rearing its head again would be not only buying a head start on any relapse but buying peace of mind. Catching cancer early = a chance of survival
100%/100% at all stages for Ovarian cancer is excellent. The...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.5¢ |
Change
0.040(7.08%) |
Mkt cap ! $66.16M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 60.5¢ | 57.0¢ | $8.493K | 14.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7372 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.5¢ | 440 | 1 |
View Market Depth
| Last trade - 10.58am 10/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |